LA JOLLA PHARMACEUTICAL CO Payments for Restructuring
LA JOLLA PHARMACEUTICAL CO reported Payments for Restructuring of $3.20 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2021-03-08
- LA JOLLA PHARMACEUTICAL CO payments for restructuring for the quarter ending 2020-12-31 was $600.00K.
- LA JOLLA PHARMACEUTICAL CO payments for restructuring for the quarter ending 2020-09-30 was -$2.20M.
- LA JOLLA PHARMACEUTICAL CO payments for restructuring for the quarter ending 2020-06-30 was $700.00K.
- LA JOLLA PHARMACEUTICAL CO payments for restructuring for the quarter ending 2020-03-31 was $3.90M.
- LA JOLLA PHARMACEUTICAL CO payments for restructuring for fiscal 2020 was $3.20M, a 255.56% increase from fiscal 2019.
- LA JOLLA PHARMACEUTICAL CO payments for restructuring for fiscal 2019 was $900.00K, a 83.33% decline from fiscal 2018.
- LA JOLLA PHARMACEUTICAL CO payments for restructuring for fiscal 2018 was $5.40M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2020-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | -$1.60M derived: sum of 2 quarters · filed 2021-03-08 | -$900.00K derived: sum of 3 quarters · filed 2021-03-08 | $3.20M 10-K · filed 2021-03-08 |
| 2020-09-30 | -$2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$1.50M derived: sum of 2 quarters · filed 2020-11-09 | $2.60M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $700.00K 10-Q · filed 2020-08-06 | $4.80M 10-Q · filed 2020-08-06 | ||
| 2020-03-31 | $3.90M 10-Q · filed 2020-05-04 | |||
| 2019-12-31 | $900.00K 10-K · filed 2020-03-02 | |||
| 2018-12-31 | $5.40M 10-K · filed 2019-03-04 |